CYP cynata therapeutics limited

9 Sept Interview BioInformant Dr Macdonald, page-3

  1. 308 Posts.
    lightbulb Created with Sketch. 248
    Over expansion of MSCs in culture causes senescence (the condition or process of deterioration with age. loss of a cell's power of division and growth). A fairly recent and ever growing body of literature can attest to this.

    TEMCELL and all other first-generation methods of manufacturing (bone-marrow MSCs etc) have proved that MSCs work (thanks to all who paved the way!), but they cannot produce enough potent and consistent cells on an industrial commercial scale.

    https://hotcopper.com.au/threads/in...3595554/page-44?post_id=26539938#.WbzPctOg9zk

    No CR on the horizon.... cash runway deep into second half of 2018.

    Excellent results from PoC Asthma studies. Which Pharma is lurking in the background?

    FOMO will kick-in soon and this will smash through a $1.50 by Christmas.

    The growth potential of this stock is ENORMOUS.



    $300-500mill MC (but worth $1bn+... )
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
15.0¢
Change
-0.010(6.25%)
Mkt cap ! $33.89M
Open High Low Value Volume
16.0¢ 16.5¢ 15.0¢ $56.28K 372.9K

Buyers (Bids)

No. Vol. Price($)
4 27422 15.0¢
 

Sellers (Offers)

Price($) Vol. No.
16.5¢ 94913 3
View Market Depth
Last trade - 16.10pm 11/07/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.